Skip to main content
Convatec Group PLC logo

Convatec Group PLC — Investor Relations & Filings

Ticker · CTEC ISIN · GB00BD3VFW73 LEI · 213800LS272L4FIDOH92 IL Manufacturing
Open in API
Filings indexed 480 across all filing types
Latest filing 2023-02-27 Director's Dealing
Country GB United Kingdom
Listing IL CTEC

About Convatec Group PLC

https://www.convatecgroup.com/

Convatec is a global medical products and technologies company focused on developing and marketing solutions for the management of chronic conditions. The company holds leading market positions in its four core franchises: Advanced Wound Care, which includes products for acute and chronic wounds; Ostomy Care, providing devices for people with stomas; Continence and Critical Care, offering solutions for bladder and bowel management; and Infusion Care, which supplies devices for subcutaneous drug delivery, primarily for insulin-dependent diabetes. Its products are designed to improve patient outcomes, prevent infection, protect at-risk skin, and reduce the total cost of care for healthcare providers and patients globally.

Recent filings

Filing Released Lang Actions
Convatec Group PLC: Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is titled 'Convatec Group PLC: Director/PDMR Shareholding' and details transactions (vesting and subsequent sale) of shares by an executive (Karim Bitar, CEO) related to the Long Term Incentive Plan (LTIP). This directly corresponds to the definition of reporting personal share transactions by company directors and executives, which is classified as Director's Dealing (DIRS). The structure includes mandatory notification tables for transactions by Persons Discharging Managerial Responsibilities (PDMRs).
2023-02-27 English
Convatec Group PLC: Appointment of Joint Corporate Broker
Regulatory Filings Classification · 1% confidence The document is a short announcement (1589 characters) disseminated via EQS Group, titled 'Convatec Group Plc: Appointment of Joint Corporate Broker'. This announcement details a change in the company's advisory team (appointment of a new corporate broker). This type of personnel/advisory change involving senior roles or key external advisors falls under the category of Board/Management Information (MANG), as it relates to the operational leadership structure, even if it's a broker rather than a director. It is not a full financial report (10-K, IR, ER) nor a general regulatory filing (RNS), but a specific announcement about management/advisory structure.
2022-12-21 English
Convatec Group PLC: Director/ PDMR Shareholding
Director's Dealing Classification · 1% confidence The document explicitly states it is a 'Director/PDMR Shareholding' notification concerning a transaction (purchase of shares) by the Chief Financial Officer (Jonny Mason), who is a Person Discharging Managerial Responsibilities (PDMR). This type of filing reports personal share transactions by company directors and executives. This directly matches the definition for Director's Dealing (Code: DIRS). The document is short and appears to be a regulatory disclosure rather than a comprehensive report.
2022-12-20 English
Convatec Group PLC: Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states it is a 'Regulatory Announcement' regarding 'Total Voting Rights' as of a specific date (30 November 2022). It cites compliance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1 and provides the total number of shares with voting rights, which is used by shareholders to calculate their notification obligations. This content directly relates to changes in share structure or ownership notification requirements, but the specific nature of announcing the total voting rights denominator aligns most closely with official regulatory disclosures concerning share capital structure. While it is a regulatory announcement, the specific content—Total Voting Rights—is a distinct type of filing. Reviewing the definitions, none perfectly match 'Total Voting Rights' announcement. However, this type of disclosure often falls under general regulatory updates or share capital changes. Since it is a mandatory disclosure related to the denominator for shareholder notification rules, it is closely related to share structure. Given the options, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the closest fit, as it deals with voting rights, although DVA is usually for *results* of a vote, this is about the *basis* for voting rights calculation. Alternatively, it could be a general 'Regulatory Filing' (RNS). Since the core subject is the total number of voting shares, which is a fundamental aspect of shareholder rights and voting, DVA is a plausible classification, but RNS is the safest fallback for specific regulatory disclosures not explicitly listed. Let's re-examine the definitions. DVA is for 'Official results from shareholder votes'. This is not results, but the total share count. Therefore, RNS (Regulatory Filings - general fallback) is the most appropriate category for this specific mandatory disclosure that doesn't fit the other specific categories like DIV, SHA, or DVA.
2022-11-30 English
Capital Markets Event
Report Publication Announcement Classification · 1% confidence The document is an official announcement disseminated via RNS (RNS Number : 6928G) from Convatec Group PLC. The primary subject is the announcement of a 'Capital Markets Event' scheduled for the same day, detailing the presentation topics, financial targets (organic revenue growth, margin expansion), and recent financing activities (refinancing bank facilities). Crucially, the document states: 'The Group will not be disclosing any new material information at today's event.' and later mentions: 'A copy of the presentation will be available on Convatec's website after the event'. This structure—announcing an event where materials will follow later—is characteristic of a Report Publication Announcement (RPA), which signals the upcoming release or availability of detailed investor materials (like an Investor Presentation or strategy update). It is not the presentation itself (IP) or a formal regulatory report like a 10-K or IR. Since it is announcing the publication of investor/strategy materials, RPA is the most fitting category.
2022-11-17 English
Trading update for ten months to 31 October 2022
Earnings Release Classification · 1% confidence The document is titled 'Trading update for the ten months ended 31 October 2022' and provides key financial highlights, including revenue growth figures (reported, constant currency, and organic) and an update to the full-year organic revenue guidance. It explicitly states that the company will update the market further at a Capital Markets Event on November 17th. This content structure—a brief update on recent performance and guidance revision outside of a full quarterly or annual filing—is characteristic of an Earnings Release (ER). Although it mentions an upcoming event, the core content is the financial performance summary, not just an announcement of a report's publication (which would be RPA/RNS). The RNS Number and the closing statement confirm it is a regulatory news service announcement, but the content itself maps best to ER. 9M 2022
2022-11-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.